Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
-3.24%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$73.5B
AUM Growth
-$7.73B
(-9.5%)
Cap. Flow
-$10.9B
Cap. Flow
% of AUM
-14.85%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
2,580
New
227
Increased
861
Reduced
712
Closed
243
Top Buys
| 1 |
PPL Corp
PPL
|
+$274M |
| 2 |
Boeing
BA
|
+$220M |
| 3 |
Estee Lauder
EL
|
+$219M |
| 4 |
Fidelity National Information Services
FIS
|
+$160M |
| 5 |
Kenvue
KVUE
|
+$151M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$517M |
| 2 |
Union Pacific
UNP
|
+$430M |
| 3 |
Pinnacle West Capital
PNW
|
+$189M |
| 4 |
Wells Fargo
WFC
|
+$189M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| 1 | Technology | 19.75% |
| 2 | Healthcare | 13.74% |
| 3 | Financials | 13.34% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1876
OmniAb
OABI
$229M
| $22K | ﹤0.01% |
4,341
| – | – |
|
1877
Belpointe PREP
OZ
$242M
| $22K | ﹤0.01% |
+260
| New | +$22K |
|
|
BLUE
1878
DELISTED
bluebird bio
BLUE
| $21K | ﹤0.01% |
363
+17
| +5% | +$983 |
|
1879
Caribou Biosciences
CRBU
$171M
| $21K | ﹤0.01% |
4,652
+188
| +4% | +$849 |
|
|
MGIC
1880
Magic Software Enterprises
MGIC
$982M
| $21K | ﹤0.01% |
1,908
-3,572
| -65% | -$39.3K |
|
1881
Magnite
MGNI
$3.47B
| $21K | ﹤0.01% |
2,790
| – | – |
|
1882
Stoke Therapeutics
STOK
$1.21B
| $21K | ﹤0.01% |
5,557
+2,723
| +96% | +$10.3K |
|
1883
Tucows
TCX
$193M
| $21K | ﹤0.01% |
1,074
| – | – |
|
1884
Alto Ingredients
ALTO
$88.2M
| $20K | ﹤0.01% |
+4,710
| New | +$20K |
|
1885
Ambac
AMBC
$426M
| $20K | ﹤0.01% |
1,691
| – | – |
|
1886
JPMorgan BetaBuilders US Equity ETF
BBUS
$5.41B
| $20K | ﹤0.01% |
261
| – | – |
|
1887
CryoPort
CYRX
$503M
| $20K | ﹤0.01% |
1,503
-1,099
| -42% | -$14.6K |
|
1888
DigitalOcean
DOCN
$3.12B
| $20K | ﹤0.01% |
854
+462
| +118% | +$10.8K |
|
1889
Phinia Inc
PHIN
$2.29B
| $20K | ﹤0.01% |
+761
| New | +$20K |
|
1890
Sangamo Therapeutics
SGMO
$157M
| $20K | ﹤0.01% |
35,051
-45,027
| -56% | -$25.7K |
|
|
SLN
1891
Silence Therapeutics
SLN
$246M
| $20K | ﹤0.01% |
+2,170
| New | +$20K |
|
|
TSVT
1892
DELISTED
2seventy bio
TSVT
| $20K | ﹤0.01% |
5,302
+226
| +4% | +$853 |
|
1893
Textron
TXT
$14.4B
| $20K | ﹤0.01% |
+259
| New | +$20K |
|
1894
Univest Financial
UVSP
$903M
| $20K | ﹤0.01% |
1,201
| – | – |
|
1895
Arcellx
ACLX
$4B
| $19K | ﹤0.01% |
553
+28
| +5% | +$962 |
|
1896
Cabot Corp
CBT
$4.31B
| $19K | ﹤0.01% |
+277
| New | +$19K |
|
1897
FS Bancorp
FSBW
$318M
| $19K | ﹤0.01% |
667
| – | – |
|
1898
H.B. Fuller
FUL
$3.39B
| $19K | ﹤0.01% |
284
| – | – |
|
1899
Nu Skin
NUS
$570M
| $19K | ﹤0.01% |
907
| – | – |
|
1900
uniQure
QURE
$960M
| $19K | ﹤0.01% |
2,930
+134
| +5% | +$869 |
|